View

If you are scraping this block for the prefixes that a AS originates, please use the data dumps in https://bgp.tools/kb/api and cache them

	Prefix	Description
	43.229.159.0/24	Baxalta Incorporated
	195.216.225.0/24	Takeda Pharmaceuticals U.S.A., Inc.
	198.102.213.0/24	Transkaryotic Therapies Inc.
	67.131.130.0/24	SHIRE PHARMACEUTICALS

---

Network Policy

Click here to learn more about what this graph means and what makes up a network policy Global Aggregation (disabled due to size) Policy wonderful_franklin Policy sleepy_dhawan Policy trusting_goldwasser

Chart Display Options

Display links using non straight lines

Prefixes in selected policy

Load all prefixes in policy

---

How are upstreams and downstreams calculated?

Upstreams

	ASN	Description	IPv4	IPv6
	AS701	Verizon Business	✔	✘
	AS46887	Crown Castle Fiber LLC	✔	✘
	AS13237	euNetworks GmbH	✔	✘
	AS209	Lumen (ex. Qwest)	✔	✘
	AS8220	COLT	✔	✘

---

Peers

	ASN	Description	IPv4	IPv6
	AS701	Verizon Business	✔	✘
	AS13237	euNetworks GmbH	✔	✘
	AS46887	Crown Castle Fiber LLC	✔	✘
	AS209	Lumen (ex. Qwest)	✔	✘
	AS8220	COLT	✔	✘

aut-num:        AS29207
as-name:        SHIRE-UK-AS
org:            ORG-SPL13-RIPE
import:         from AS5089 action pref=100; accept ANY
import:         from AS1239 action pref=100; accept ANY
import:         from AS6939 action pref=100; accept ANY
export:         to AS5089 announce AS29207
export:         to AS1239 announce AS29207
export:         to AS6939 announce AS29207
default:        to AS1239 action pref=100; networks ANY
admin-c:        DUMY-RIPE
tech-c:         DUMY-RIPE
status:         ASSIGNED
mnt-by:         RIPE-NCC-END-MNT
mnt-by:         SHIRE-MNT
notify:         dl.Network.Lt@takeda.com
notify:         dl.Network.Lt@takeda.com
remarks:        mnt-by: SHIRE-MNT
remarks:        mnt-routes: SHIRE-MNT
created:        2003-07-01T07:56:33Z
last-modified:  2025-10-16T10:26:45Z
source:         RIPE
remarks:        ****************************
remarks:        * THIS OBJECT IS MODIFIED
remarks:        * Please note that all data that is generally regarded as personal
remarks:        * data has been removed from this object.
remarks:        * To view the original object, please query the RIPE Database at:
remarks:        * http://www.ripe.net/whois
remarks:        ****************************


organisation:   ORG-SPL13-RIPE
org-name:       Takeda Pharmaceuticals U.S.A., Inc.
country:        US
org-type:       LIR
address:        Dummy address for ORG-SPL13-RIPE
# Email removed, Log into bgp.tools to see whois emails
abuse-c:        AC31348-RIPE
mnt-by:         SHIRE-MNT
mnt-ref:        SHIRE-MNT
mnt-ref:        RIPE-NCC-HM-MNT
mnt-by:         RIPE-NCC-HM-MNT
created:        2013-12-11T09:35:52Z
last-modified:  2025-10-16T10:58:35Z
source:         RIPE
remarks:        ****************************
remarks:        * THIS OBJECT IS MODIFIED
remarks:        * Please note that all data that is generally regarded as personal
remarks:        * data has been removed from this object.
remarks:        * To view the original object, please query the RIPE Database at:
remarks:        * http://www.ripe.net/whois
remarks:        ****************************

Last Update: 2025-12-22T03:24:31Z UTC

---

Member of the following AS-SETs

-	Member	ASN Count
RADB	as-ccf	1492
RIPE	as-bt-ie	104
RIPE	as-transroute-spec	19683
RADB	as-ccf-test	1461
LEVEL3	as-lumen-customers-asns	10695
RIPE	as207044:as-enet	37
APNIC	as-63529-as-import-as6939	38131
RIPE	as-eunie	54
RIPE	as8220:as-coltie	77
LEVEL3	as-as209-cust	1818